2023-507836-19-00招募中1 期
Phase I dose escalation study of DPPG2-TSL-DOX combined with hyperthermia in soft tissue sarcoma
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 18
- 试验地点
- 2
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical Development
Scientific
Thermosome GmbH
研究点 (2)
Loading locations...
相似试验
招募中
2 期
A Phase I/II Study of AZD5863 in Adult Participants with Advanced or Metastatic Solid Tumors2023-504139-42-00AstraZeneca AB48
招募中
2 期
A Phase 1/2a gene therapy clinical trial in Retinitis Pigmentosa subjects.2024-516059-42-00Gensight Biologics9
招募中
1/2 期
A phase I dose-escalation study testing the feasibility and the tolerance of infusion of a third party suicide gene-transduced anti-HLA-DPB1*0401 cytotoxic T cell clone in patients with HLA-DPB1*0401 positive hematologic malignancies and receiving an allotransplant from HLA-DPB1*0401 negative donors2024-515504-39-00Centre Hospitalier Universitaire De Nantes6
已完成
1 期
A phase 1/2a study to evaluate the dose, safety, tolerability, and efficacy of an intraperitoneal α-emitting radionuclide therapy (Radspherin®) in subjects with peritoneal carcinomatosis from colorectal carcinoma following hyperthermic intraperitoneal chemotherapy2024-511853-23-00Oncoinvent ASA54
招募中
2 期
An Open label Study of Teclistamab in Subjects with Relapsed and Refractory Multiple Myeloma2023-503438-40-00Janssen - Cilag International267